Hamamatsu Pharma Research
Preclinical contract research organization focused on development and characterization of cynomolgus macaque (nonhuman primate) disease models and preclinical efficacy evaluation of therapeutic candidates. Provides noninvasive longitudinal in vivo imaging, pharmacological testing, and specialized animal care compliant with international animal welfare standards.
Industries
Nr. of Employees
small (1-50)
Hamamatsu Pharma Research
Products
Preclinical Efficacy Testing in Cynomolgus Macaque Disease Models
Provides drug efficacy testing using cynomolgus macaque models to evaluate potential therapeutics in various disease areas.
Noninvasive Medical Imaging
Offers in vivo imaging techniques including MRI, CT, and functional MRI to monitor disease progression and therapeutic effects in nonhuman primates.
Pharmacological Consultation and Study Design
Provides expert consultation and study protocol design for preclinical pharmacological research using nonhuman primate models.
Custom Disease Model Development and Model Customization
Develops and customizes nonhuman primate disease models tailored to specific research needs and therapeutic areas.
Preclinical Efficacy Testing in Cynomolgus Macaque Disease Models
Provides drug efficacy testing using cynomolgus macaque models to evaluate potential therapeutics in various disease areas.
Noninvasive Medical Imaging
Offers in vivo imaging techniques including MRI, CT, and functional MRI to monitor disease progression and therapeutic effects in nonhuman primates.
Pharmacological Consultation and Study Design
Provides expert consultation and study protocol design for preclinical pharmacological research using nonhuman primate models.
Custom Disease Model Development and Model Customization
Develops and customizes nonhuman primate disease models tailored to specific research needs and therapeutic areas.
Services
NHP disease model development
Create and characterize cynomolgus macaque disease models for preclinical research across multiple therapeutic areas.
Preclinical efficacy evaluation
Contract pharmacological studies and efficacy testing of therapeutic candidates in NHP models prior to clinical development.
Noninvasive in vivo imaging services
Provide MRI, CT, and fluoroscopy imaging for longitudinal assessment of disease progression and treatment response.
Pain evaluation using fMRI
Use functional MRI and stimulation paradigms to quantify brain activation linked to pain states in NHP models.
Ophthalmology assessments
Conduct ocular examinations and retinal imaging including funduscopy and OCT in preclinical models.
Pharmacology and biomarker analysis
Perform dosing studies, behavioral and functional endpoint measurements, and clinical laboratory analyses such as blood chemistry.
NHP disease model development
Create and characterize cynomolgus macaque disease models for preclinical research across multiple therapeutic areas.
Preclinical efficacy evaluation
Contract pharmacological studies and efficacy testing of therapeutic candidates in NHP models prior to clinical development.
Noninvasive in vivo imaging services
Provide MRI, CT, and fluoroscopy imaging for longitudinal assessment of disease progression and treatment response.
Pain evaluation using fMRI
Use functional MRI and stimulation paradigms to quantify brain activation linked to pain states in NHP models.
Ophthalmology assessments
Conduct ocular examinations and retinal imaging including funduscopy and OCT in preclinical models.
Pharmacology and biomarker analysis
Perform dosing studies, behavioral and functional endpoint measurements, and clinical laboratory analyses such as blood chemistry.
Expertise Areas
- Nonhuman primate disease model development
- Preclinical efficacy evaluation
- In vivo longitudinal imaging
- Neuroimaging and pain assessment
Key Technologies
- Magnetic resonance imaging (MRI)
- Functional MRI (fMRI)
- Diffusion tensor imaging (DTI)
- Perfusion MRI